RepoMed (Medizinische Hochschule Hannover)
Not a member yet
    3024 research outputs found

    Einfluss von Lipoproteinrezeptoren und lipidsenkenden Medikamenten auf den Hepatitis-C-Replikationszyklus

    No full text

    NEWS RESIST - Resolving Infection Susceptibility 02/2024

    No full text

    New translational mouse models for metabolic dysfunction-associated steatotic liver disease comparable to human MASLD with severe obesity

    No full text
    Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common cause of chronic liver disease, in particular in patient with severe obesity. However, common mouse models for MASLD do neither represent a polygenetic background nor the metabolic changes in this population. Therefore, we investigated two new mouse models for MASLD with the polygenetic background for the metabolic syndrome. Methods: TALLYHO/JngJ mice and NONcNZO10/LtJ mice received a high-fat- high-carbohydrate (HF-HC) diet with a surplus of cholesterol diet. Results: After sixteen weeks of diet, both strains developed pronounced metabolic syndrome with severe obesity and histological manifestation of steatohepatitis. Subsequently, histological onset of MASH was associated with significantly increased intrahepatic CD8+cells, CD4+cells and Tregs, contributing to significant increase of pro-inflammatory and pro-fibrotic gene activation as well as ER stress and oxidative stress. Comparing with human transcriptomic signature, we could proof a good metabolic resemblance in particular for TH mouse model. Moreover, TH mice also developed sings of kidney injury as an extrahepatic comorbidity of MASLD. Conclusion: Overall, we developed two promising new mouse models, which are suitable for preclinical investigations of MASLD as they recapitulate most important hallmarks of MASLD

    The enigma of small heat shock protein phosphorylation

    No full text

    Maximal versorgt: 50 Jahre Kinderklinik

    No full text

    Low-value surgical innovation under peer-review: a sham study of abstracts on proximal humerus fractures submitted to scientific meetings

    No full text
    Background Innovation has in common the promise of benefit for patients; however, past experience has shown that this promise is not always delivered. Instead, low-value innovation might encourage treatment variation and dilute the available body of evidence. This study aims to investigate (1) whether the peer-review process is capable of filtering out low-value innovation appropriately, and (2) whether low-value surgical innovation would be preferred more often than nonoperative innovation by peer-reviewers in the treatment of proximal humeral fractures in the elderly. Materials and methods Two duplicated sham scientific abstracts, respectively introducing a low-value surgical innovation and a valuable nonsurgical innovation, were submitted to nineteen peer-reviewed scientific meetings worldwide for orthopedic trauma surgery with submission deadlines between 01/01/2022 and 31/12/2022. Decision regarding abstract acceptance was compared. Results There was a high acceptance rate for the abstract introducing low-value surgical innovation (12 out of 19 (63.2 %)), which was higher than that of a nonoperative duplicate (10 out of 19 (52.6 %)), but this difference was not statistically significant (p = 0.5). The majority of the ten meetings that accepted both abstracts placed both in equivalent programmatic tiers (oral presentation (4) and poster presentation (2)). In three meetings, the surgical abstract received superior program placement (oral presentation). In one case, it was the opposite. Conclusion There is a high acceptance rate for low-value surgical innovation among peer-reviewed scientific meetings. However, we can not conclude that low-value surgical innovation is preferred more often than nonoperative innovation by peer-reviewers as the differences in acceptance rate were small and not statistically significant. The peer-review process may be suitable as value-based medicine emerges. Scientists should be encouraged to pursue value-based innovation

    1,323

    full texts

    3,024

    metadata records
    Updated in last 30 days.
    RepoMed (Medizinische Hochschule Hannover)
    Access Repository Dashboard
    Do you manage Open Research Online? Become a CORE Member to access insider analytics, issue reports and manage access to outputs from your repository in the CORE Repository Dashboard! 👇